logo-loader
viewProactive Group

Balamara Resources defines maiden coal resource in Poland in just eight months

au_poland350_535dd4d037363.jpg

Balamara Resources (ASX: BMB) has estimated a maiden JORC Resource of 23.06 million tonnes of coal at its Nowa Ruda coking coal project in Poland.

The company also estimated an Exploration Target ranging from 112.50Mt to 160.71Mt for the two principal coking coal deposits at Nowa Ruda.

Drilling is currently being carried out by three diamond drill rig aimed at converting further coal tonnages currently within the Exploration Target to JORC resources.

The maiden JORC Resource and Exploration Target is derived only from existing historical data and information collected over the past 25 years and made available to Balamara.

It is expected that a series of resource update announcements will follow over the next 3‐6 months as current exploration work fills in the gaps in geological knowledge and seeks to verify the historical data.

Nowa Ruda is a large historical underground coal mine consisting of two adjacent deposits, Wacław and Lech, which produced substantial coking coal throughout the last century.

Balamara acquired the project through the award of a concession in July 2013. This gives Balamara the right to explore the two existing deposits and take the project into production following completion of a successful Feasibility Study and the granting of a licence to mine.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Redx Pharma's chief scientific officer talks grant funding for its fibrosis...

Redx Pharma PLC's (LON:REDX) chief scientific officer Dr Richard Armer speaks to Proactive London's Andrew Scott after announcing they'd won grant funding for their latest project. They're collaborating with the Medicines Discovery Catapult, a government body that helps accelerate the...

56 minutes ago

2 min read